相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A phase IV, double-blind, multicentre, randomized, placebo-controlled, pilot study to assess the feasibility of switching individuals receiving efavirenz with continuing central nervous system adverse events to etravirine
Laura Waters et al.
AIDS (2011)
The MONET trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV RNA below 50 copies/ml
Jose R. Arribas et al.
AIDS (2010)
Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials
Joseph J. Eron et al.
LANCET (2010)
Efficacy and tolerability of initial antiretroviral therapy: a systematic review
Andrew Carr et al.
AIDS (2009)
Efficacy and Safety of Atazanavir, With or Without Ritonavir, as Part of Once-Daily Highly Active Antiretroviral Therapy Regimens in Antiretroviral-Naive Patients
D. R (Niel) Malan et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2009)
Lopinavir-Ritonavir Monotherapy Versus Lopinavir-Ritonavir and 2 Nucleosides for Maintenance Therapy of HIV: 96-Week Analysis
Jose R. Arribas et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2009)
Efficacy and safety of replacing lopinavir with atazanavir in HIV-infected patients with undetectable plasma viraemia: final results of the SLOAT trial
Vincent Soriano et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Three- vs four-drug antiretroviral regimens for the initial treatment of HIV-1 infection - A randomized controlled trial
Roy M. Gulick et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
HIV protease inhibitor substitution in patients with lipodystrophy: a randomized, controlled, open-label, multicentre study
A Carr et al.
AIDS (2001)
分享论文
